Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Biometrika. 2013 May 14;100(3):741–755. doi: 10.1093/biomet/ast012

Table 4.

Analysis results for diabetes data.

NPMLEg NPMLEl GehanR
Est. SE pv Est. SE pv Est. SE pv
treatment −0.929 .104 .000 −0.949 .105 .000 −0.981 .201 .000
age 0.011 .006 .078 0.008 .006 .162 0.010 .016 .551
type −0.029 .102 .779 0.070 .096 .467 −0.301 .453 .506
risk 1.660 .353 .000 1.491 .346 .000 2.568 1.036 .013

NPMLEg, nonparametric maximum likelihood estimator with the gamma frailty; NPMLEl, nonparametric maximum likelihood estimator with the log-normal frailty; GehanR, Gehan rank estimator; Est., estimated coefficients; pv, p-value; age, age at diagnosis of diabetes; type, type of diabetes; risk, risk group.